Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
8,477,992
-
Share change
-
+8,477,992
-
Total reported value
-
$145,818,000
-
Price per share
-
$17.35
-
Number of holders
-
35
-
Value change
-
+$145,818,000
-
Number of buys
-
35
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2015
As of 31 Mar 2015,
Ascendis Pharma A/S - ADR (ASND) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,477,992 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, FMR LLC, VHCP Management, LLC, Sectoral Asset Management Inc, RS INVESTMENT MANAGEMENT CO LLC, Pictet Asset Management Ltd, GREAT POINT PARTNERS LLC, Visium Asset Management, LP, and Longwood Capital Partners LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.